The synergistic apoptotic interaction of panaxadiol and epigallocatechin gallate in human colorectal cancer cells

Phytotherapy Research

Volumn 27, Issue 2, 2013, Pages 272-277

  Du, Guang Jian ^a,b   Wang, Chong Zhi ^a,b   Qi, Lian Wen ^a,b   Zhang, Zhi Yu ^a,b   Calway, Tyler ^a,b   He, Tong Chuan ^b   Du, Wei ^c   Yuan, Chun Su ^a,b,d  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

antiproliferation; apoptosis; cell cycle; docking analysis; epigallocatechin gallate; human colorectal cancer; panaxadiol

Indexed keywords

EPIGALLOCATECHIN GALLATE; LIPOCORTIN 5; PANAXADIOL; RIBONUCLEASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL ASSAY; CELL CYCLE S PHASE; CELL FRACTIONATION; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN HCT116; CELL STRAIN SW 480; COLORECTAL CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; DRUG STRUCTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOLECULAR DOCKING;

ANNEXIN A5; APOPTOSIS; CATECHIN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DRUG SYNERGISM; GINSENOSIDES; HUMANS; MOLECULAR DOCKING SIMULATION;

EID: 84870606609     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4707     Document Type: Article

References (29)

1. Cabrera C, Artacho R, Gimenez R,. 2006. Beneficial effects of green tea-a review. J Am Coll Nutr 25: 79-99.
2. Choi KT,. 2008. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer. Acta Pharmacol Sin 29: 1109-18.
3. Cragg GM, Grothaus PG, Newman DJ,. 2009. Impact of natural products on developing new anti-cancer agents. Chem Rev 109: 3012-43.
4. Du GJ, Dai Q, Williams S, Wang CZ, Yuan CS,. 2011. Synthesis of protopanaxadiol derivatives and evaluation of their anticancer activities. Anticancer Drugs 22: 35-45.
5. Gerke V, Moss SE,. 2002. Annexins: from structure to function. Physiol Rev 82: 331-71.
6. Gullett NP, Ruhul Amin AR, Bayraktar S, et al., 2010. Cancer prevention with natural compounds. Semin Oncol 37: 258-81.
7. Hartwell LH, Weinert TA,. 1989. Checkpoints: controls that ensure the order of cell cycle events. Science 246: 629-34.
8. Hawk ET, Levin B,. 2005. Colorectal cancer prevention. J Clin Oncol 23: 378-91.
9. Helms S,. 2004. Cancer prevention and therapeutics: Panax ginseng. Altern Med Rev 9: 259-74.
10. Jang HI, Shin HM,. 2010. Wild Panax ginseng (Panax ginseng C.A. Meyer) protects against methotrexate-induced cell regression by enhancing the immune response in RAW 264.7 macrophages. Am J Chin Med 38: 949-60.
11. Jemal A, Siegel R, Xu J, Ward E,. 2010. Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
12. Kawai K, Tsuno NH, Kitayama J, et al., 2005. Epigallocatechin gallate induces apoptosis of monocytes. J Allergy Clin Immunol 115: 186-91.
13. Kim MJ, Kim HI, Chung J, Jeong TS, Park HR,. 2009. (-)-Epigallocatechin- 3-gallate (EGCG) increases the viability of serum-starved A549 cells through its effect on Akt. Am J Chin Med 37: 723-34.
14. Lambert JD, Elias RJ,. 2010. The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch Biochem Biophys 501: 65-72.
15. Li B, Wang CZ, He TC, Yuan CS, Du W,. 2010. Antioxidants potentiate American ginseng-induced killing of colorectal cancer cells. Cancer Lett 289: 62-70.
16. Monceau V, Belikova Y, Kratassiouk G, et al., 2004. Externalization of endogenous annexin A5 participates in apoptosis of rat cardiomyocytes. Cardiovasc Res 64: 496-506.
17. Nakazato T, Ito K, Ikeda Y, Kizaki M,. 2005. Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species. Clin Cancer Res 11: 6040-9.
18. Qi LW, Wang CZ, Yuan CS,. 2010. American ginseng: potential structure-function relationship in cancer chemoprevention. Biochem Pharmacol 80: 947-54.
19. Qi LW, Wang CZ, Yuan CS,. 2011. Isolation and analysis of ginseng: advances and challenges. Nat Prod Rep 28: 467-95.
20. Rodriguez M, Du GJ, Wang CZ, Yuan CS,. 2010. Letter to the editor: Panaxadiol's anticancer activity is enhanced by epicatechin. Am J Chin Med 38: 1233-5.
21. Singh BN, Shankar S, Srivastava RK,. 2011. Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications. Biochem Pharmacol 82: 1807-21.
22. Sun S, Qi LW, Du GJ, Mehendale SR, Wang CZ, Yuan CS,. 2011. Red notoginseng Higher ginsenoside content and stronger anticancer potential than Asian and American ginseng. Food Chem 125: 1299-305.
23. van Genderen HO, Kenis H, Hofstra L, Narula J, Reutelingsperger CP,. 2008. Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization. Biochim Biophys Acta 1783: 953-63.
24. Wang CZ, Aung HH, Ni M, et al., 2007. Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots. Planta Med 73: 669-74.
25. Wang CZ, Li XL, Wang QF, et al., 2009. The mitochondrial pathway is involved in American ginseng-induced apoptosis of SW-480 colon cancer cells. Oncol Rep 21: 577-84.
26. Wang CZ, Zhang B, Song WX, et al., 2006. Steamed American ginseng berry: ginsenoside analyses and anticancer activities. J Agric Food Chem 54: 9936-42.
27. Yang CS, Wang X, Lu G, Picinich SC,. 2009. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9: 429-39.
28. Yao Y, Zhao H, Sun Y, Lin F, Tang L, Chen P,. 2008. Combined chemotherapy of hydroxycampothecin with oxaliplatin as an adjuvant treatment for human colorectal cancer. Tohoku J Exp Med 215: 267-78.
29. Zhang R, Jie J, Zhou Y, Cao Z, Li W,. 2009. Long-term effects of Panax ginseng on disposition of fexofenadine in rats in vivo. Am J Chin Med 37: 657-67.